Peptide Epitope-Based Avian Igy Antibodies Against Sars-Cov-2 Spike: A Cost Effective Approach for Viral Detection and Neutralization
Опубликована: Янв. 1, 2025
Язык: Английский
The efficacy and safety of hydroxychloroquine at different doses and courses for COVID-19 prevention: a systematic review and network meta-analysis
Expert Review of Anti-infective Therapy,
Год журнала:
2024,
Номер
unknown, С. 1 - 12
Опубликована: Окт. 4, 2024
The
optimal
strategy
for
using
hydroxychloroquine
to
prevent
coronavirus
disease
2019
(COVID-19)
in
patients,
either
before
or
after
exposure,
remains
unclear.
We
evaluated
the
safety
and
efficacy
of
different
doses
treatment
durations
COVID-19
prevention.
Язык: Английский
Paving the way for quality assured, decentralised point-of-care testing for infectious disease in primary care - Real world lessons from remote Australia
Expert Review of Molecular Diagnostics,
Год журнала:
2024,
Номер
unknown, С. 1 - 14
Опубликована: Дек. 24, 2024
Introduction
Decentralized
molecular
testing
for
infectious
disease
diagnosis
at
the
point-of-care
(POC)
is
critical
to
address
inequities
in
access
timely,
informed
health
care.
The
COVID-19
pandemic
accelerated
demand,
development
and
adoption
of
POC
tests
diseases
globally.
This
has
provided
opportunities
maximize
individual
benefits
public
impact
testing,
particularly
remote
resource-limited
primary
care
settings.
Despite
this,
there
remains
a
lack
harmonized,
regulatory
compliance
quality
management
frameworks
delivery
networks
outside
laboratory
setting.
Язык: Английский